MIST-PPF Clinical Trial Overview: Studying inhaled Pirfenidone in the treatment of progressive pulmonary fibrosis

Get an overview of Avalyn Pharma Inc.’s MIST-PPF Clinical Trial which aims to study inhaled Pirfenidone in the treatment of progressive pulmonary fibrosis and determine if breathing in the medicine will help reach the lungs more directly where it’s needed most, while reducing the amount that goes to other parts of the body, meaning potentially fewer side effects.

Learn about previous clinical trial results, how to participate if you have progressive pulmonary fibrosis, and what to expect.

Sign up for the webinar below.
Live stream will start at 6:10 PM EDT on March 18, 2026.